Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 12.6
(-0.24%)
CNY 12.6
(-0.24%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 54.66 Million CNY | -30.85% |
| 2022 | 79.06 Million CNY | -47.77% |
| 2021 | 151.37 Million CNY | -27.1% |
| 2020 | 207.64 Million CNY | -22.52% |
| 2019 | 268.01 Million CNY | -9.94% |
| 2018 | 297.6 Million CNY | -8.32% |
| 2017 | 324.6 Million CNY | 305.75% |
| 2016 | 80 Million CNY | -20.0% |
| 2015 | 100 Million CNY | 86330.42% |
| 2014 | 115.7 Thousand CNY | -31.58% |
| 2013 | 169.1 Thousand CNY | -24.0% |
| 2012 | 222.5 Thousand CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 9 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 84.09 Million CNY | 9.21% |
| 2024 Q1 | 77 Million CNY | 40.86% |
| 2024 Q3 | 84.08 Million CNY | 8.66% |
| 2023 Q1 | 76.59 Million CNY | -3.12% |
| 2023 FY | 54.66 Million CNY | -30.85% |
| 2023 Q2 | 65.15 Million CNY | -14.94% |
| 2023 Q3 | 50.63 Million CNY | -22.28% |
| 2023 Q4 | 54.66 Million CNY | 7.97% |
| 2022 FY | 79.06 Million CNY | -47.77% |
| 2022 Q3 | 113.39 Million CNY | -6.02% |
| 2022 Q4 | 79.06 Million CNY | -30.28% |
| 2022 Q2 | 120.64 Million CNY | -18.75% |
| 2022 Q1 | 148.48 Million CNY | -1.91% |
| 2021 FY | 151.37 Million CNY | -27.1% |
| 2021 Q4 | 151.37 Million CNY | -9.57% |
| 2021 Q1 | 179.61 Million CNY | -13.5% |
| 2021 Q2 | 187.69 Million CNY | 4.49% |
| 2021 Q3 | 167.39 Million CNY | -10.81% |
| 2020 Q1 | 318.05 Million CNY | 18.67% |
| 2020 Q2 | 290.99 Million CNY | -8.51% |
| 2020 Q4 | 207.64 Million CNY | -23.93% |
| 2020 Q3 | 272.96 Million CNY | -6.2% |
| 2020 FY | 207.64 Million CNY | -22.52% |
| 2019 Q2 | 282.6 Million CNY | -5.04% |
| 2019 Q1 | 297.6 Million CNY | 0.0% |
| 2019 FY | 268.01 Million CNY | -9.94% |
| 2019 Q4 | 268.01 Million CNY | -8.09% |
| 2019 Q3 | 291.6 Million CNY | 3.18% |
| 2018 Q1 | 324.6 Million CNY | 0.0% |
| 2018 FY | 297.6 Million CNY | -8.32% |
| 2018 Q4 | 297.6 Million CNY | -5.4% |
| 2018 Q3 | 314.6 Million CNY | -1.56% |
| 2018 Q2 | 319.6 Million CNY | -1.54% |
| 2017 Q4 | 324.6 Million CNY | 399.38% |
| 2017 FY | 324.6 Million CNY | 305.75% |
| 2017 Q3 | 65 Million CNY | 8.33% |
| 2017 Q2 | 60 Million CNY | 0.0% |
| 2017 Q1 | 60 Million CNY | -25.0% |
| 2016 FY | 80 Million CNY | -20.0% |
| 2016 Q4 | 80 Million CNY | -46.67% |
| 2016 Q2 | 200.03 Million CNY | 100.03% |
| 2016 Q3 | 150 Million CNY | -25.01% |
| 2016 Q1 | 100 Million CNY | 0.0% |
| 2015 FY | 100 Million CNY | 86330.42% |
| 2015 Q3 | 50 Million CNY | 59036.61% |
| 2015 Q2 | 84.55 Thousand CNY | -17.39% |
| 2015 Q4 | 100 Million CNY | 100.0% |
| 2015 Q1 | 102.35 Thousand CNY | -11.54% |
| 2014 FY | 115.7 Thousand CNY | -31.58% |
| 2014 Q4 | 115.7 Thousand CNY | -10.34% |
| 2014 Q1 | 155.75 Thousand CNY | -7.89% |
| 2014 Q2 | 142.4 Thousand CNY | -8.57% |
| 2014 Q3 | 129.05 Thousand CNY | -9.38% |
| 2013 Q1 | 209.15 Thousand CNY | -6.0% |
| 2013 Q4 | 169.1 Thousand CNY | -7.32% |
| 2013 Q3 | 182.45 Thousand CNY | -6.82% |
| 2013 Q2 | 195.8 Thousand CNY | -6.38% |
| 2013 FY | 169.1 Thousand CNY | -24.0% |
| 2012 Q4 | 222.5 Thousand CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 FY | 222.5 Thousand CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 Q3 | 3.7 Million CNY | -58.89% |
| 2011 Q2 | 9 Million CNY | 0.0% |
| 2011 Q1 | 9 Million CNY | 0.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 FY | - CNY | -100.0% |
| 2010 FY | 9 Million CNY | 0.0% |
| 2010 Q4 | 9 Million CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |